TP53 and neoplasm: Others observed deregulation of normal LASP-1-expression in relation to changes in PDEF and urokinase-type plasminogen activator (uPA) concentration or because of loss of p53 tumour suppressor activity (Turner et al, 2008; Salvi et al, 2009; Wang et al, 2009).